The neuroprotective effects of HO-1 have been demonstrated in various models of neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis [158,159,160]. This evidence concerns the gene HMOX1 and early-onset autosomal dominant Alzheimer disease.